Summary: On October 29, 2026, BBX launched perpetual contracts for four U.S. stocks: CoreWeave ($CRWV), Bloom Energy ($BE), Oracle ($ORCL), and Moderna ($MRNA), covering three major themes: AI cloud, AI power, and mRNA biotechnology. Among them, CoreWeave is an AI computing cloud company that has received investment from Nvidia, and Bloom Energy's stock price has doubled this year, benefiting from the power supply demands of data centers. This article introduces the business operations, recent popularity, and analyst views of the four companies, and explains the differences between perpetual stock contracts and spot stocks.
On October 29, BBX (bbx.com) launched four U.S. stock perpetual contracts:
CRWVUSDT: CoreWeave (NASDAQ: $CRWV), an AI-focused cloud infrastructure company, with Nvidia as a significant shareholder
MRNAUSDT: Moderna (NASDAQ: $MRNA), a company focused on mRNA vaccines and drugs
BEUSDT: Bloom Energy (NYSE: $BE), a company that produces solid oxide fuel cells and on-site power solutions
ORCLUSDT: Oracle (NYSE: $ORCL), a provider of databases, enterprise software, and cloud infrastructure
Among these, CRWVUSDT was launched individually; MRNAUSDT, BEUSDT, and ORCLUSDT were launched simultaneously with five other cryptocurrency perpetual contracts.
All four companies have been popular stocks in the U.S. market over the past month: some have just released earnings reports, some have just held investor days, and some have announced Phase III clinical data, with daily stock price fluctuations often in double digits. Here is a detailed introduction.
It should be noted that stock perpetual contracts are derivatives that track the price of the underlying stock and are not the actual stocks. Trading these contracts does not represent holding shares in the company and does not grant shareholder rights; the contract prices may also deviate from the prices of the underlying stocks.
1. What do the four companies do?
CoreWeave ($CRWV): AI computing "new cloud" backed by Nvidia
CoreWeave brands itself as “The Essential Cloud for AI”, providing GPU computing power and cloud services for tasks such as training and inference of AI models. The company claims that 9 out of the top 10 global foundational model providers are its clients. Founded in 2017, it went public on NASDAQ in March 2025. One of its highlights is being backed by Nvidia ($NVDA). Nvidia is not only its GPU supplier but also a significant shareholder: Nvidia's 13F filing with the SEC shows that as of June 30, 2026, it holds about 47.21 million Class A shares of CoreWeave, nearly doubling from about 24.28 million shares at the end of 2025; Nvidia's 13G/A amendment filing indicates that this stockholding represents approximately 11.5% of CoreWeave’s Class A shares. According to this 13F, CoreWeave ranks third in market value among the eight stocks disclosed by Nvidia, behind only Intel and SpaceX.
As an "AI cloud" backed by Nvidia, CoreWeave is often seen as a bellwether for Nvidia's ecosystem: Nvidia's next-generation GPUs are often scaled for deployment in its data centers early.
Industry insiders refer to such companies as "neocloud": not building generalized clouds but creating specialized data centers for AI computing power.
In the secondary market, CoreWeave is one of the most closely watched and highly volatile AI stocks this year. Over the past year, its stock price peaked at about $140, dropping to around $51 on October 26, marking a more than 50% decline over the year (Finviz, as of October 28). According to WallStreetNumbers, as of October 27, its 10-day historical volatility was approximately 123%, indicating “extreme volatility”. In terms of popularity, in mid-October, its stock price dropped by about a quarter in a week, but Robinhood retail investors recorded a net purchase record for that week; on that Friday, it was the third-most bought stock on Robinhood, trailing only Tesla and SpaceX (Sherwood News). During this time, it was also among the top two stocks discussed on Stocktwits (Stocktwits, October 15).
Moderna ($MRNA): mRNA technology platform company
Moderna is known for its COVID-19 mRNA vaccine, and its product line has expanded to respiratory vaccines (COVID-19, RSV, influenza, etc.), latent virus vaccines, rare diseases, and cancer treatment. Currently, the market is most concerned about its personalized cancer vaccine intismeran autogene developed in collaboration with Merck.Bloom Energy ($BE): “On-site power generation” for AI data centers
Bloom Energy produces solid oxide fuel cell systems that can generate electricity directly on-site for users. The power consumption of AI data centers is growing rapidly, while grid access is slow, thus creating a new demand for “fast, stable, and dispatchable on-site power.” Bloom Energy's performance is bolstered by this demand. In September 2026, Bloom Energy was officially included in the S&P 500 index (Motley Fool, September 8).
It is also among the hottest AI power stocks this year. In 2025, Bloom's stock price rose over 291%; it continued to strengthen in 2026, with about a 162.5% year-to-date increase as of October 28 (CNBC; Yahoo Finance). In April, it saw a monthly increase of over 100%, with Mizuho traders describing it as “on the verge of becoming a meme stock”, indicating high retail participation (CNBC, April 29). On September 25, its stock price briefly hit a peak of around $292.7, rising about 86% over two months (TradingKey).
The market's enthusiasm for it stems from several reasons:
AI data centers are "lacking electricity": while chips are available, electricity is not. In the U.S., connecting data centers to the grid often requires years of waiting; Bloom's own research shows that the supply time provided by power companies is 1.5 to 2 years later than data center developers’ expectations (Bloom Energy 2026 Power Report). Bloom’s fuel cells can generate power directly on-site at data centers, not relying on the grid, and can be deployed quickly, with Motley Fool stating they can power data centers in about three months.
Large customers and significant funding endorsements: Oracle plans to purchase up to 2.8GW of Bloom systems and has secured warrants to purchase $400 million in Bloom stock (CNBC, April 14); Brookfield has expanded its financing cooperation framework with Bloom from $5 billion to $25 billion (Motley Fool).
Performance fulfillment: Q3 revenue grew 138% year-over-year, and the annual revenue guidance has been continuously raised, indicating that orders are converting into revenue, rather than just concepts.
Inclusion in the S&P 500: After joining the index, passive funds are required to allocate to it, further increasing attention and funding.
Continued popularity in October: After Q3 earnings report, the stock price fell sharply, but retail sentiment on Stocktwits turned from “neutral” to “very bullish”, with relevant discussion volume increasing about 486% in one day (Stocktwits, October 22).
It is worth mentioning that Oracle, which was launched alongside Bloom, is one of its major clients, and the two contracts can be compared to observe the interplay between AI cloud and AI power.
Oracle ($ORCL): Transitioning from a database giant to AI cloud
Oracle’s traditional business is in databases and enterprise software (ERP, HCM, NetSuite, etc.). In the past two years, it has aggressively entered AI cloud infrastructure (OCI), competing with large-scale cloud providers like Google and Amazon, and has provided computing power for OpenAI. According to CNBC citing FactSet data, its capital expenditures doubled in excess in fiscal year 2026, reaching $55.7 billion.
2. Why these four companies? Three main lines
Main line one: AI computing power and cloud ($CRWV + $ORCL) In October 2026, the "financing issue" of AI infrastructure is one of the most discussed topics in the U.S. market. CoreWeave and Oracle are often mentioned together in this theme: both are building data centers on a large scale, both carry high debts, and their stock prices are sensitive to interest rates and credit spreads. By launching both at the same time, users can compare and observe two types of companies within the “AI cloud” sector: one is a pure computing cloud startup, and the other is a traditional software giant undergoing transformation.
Main line two: AI electricity ($BE) The end of computing power is electricity. Bloom Energy’s growth directly benefits from the power supply demands of data centers, representing one of the key companies in the “AI + energy” intersection theme.
Main line three: Biotechnology / mRNA ($MRNA) Moderna’s recent performance is not highly correlated with the AI sector; it is mainly driven by clinical data and regulatory progress, belonging to a different category of event-driven stocks. It is grouped with the first three to cover technology + energy + medicine sectors with this new launch.
3. Recent performance and market heat
The following data comes from public sources, with dates based on Eastern Time; stock prices are closing data as of October 28, 2026, unless otherwise stated.
CoreWeave ($CRWV): rebound after a steep decline, debt is the focus
Recent performance: closed at $63.93 on October 28, up 7.32% for the day (Yahoo Finance). As of October 28, it fell about 10.7% YTD (Yahoo Finance), with a 52-week range of $51.24–$140.33, and the 52-week low occurred on October 26 (CNBC market page).
Underlying reasons: According to a CNBC report on October 21, CoreWeave’s stock price had fallen 36% that month, with unsecured bond yields around 15%, and a 5-year CDS spread reaching 1,145 basis points. Market concerns revolve around the refinancing cost of a highly indebted cloud company.
Analyst divergence: Most institutions remain bullish, but target prices differ widely, with the lowest around $39 and the highest around $318 (compiled from data from 42 institutions by Aries).
The bullish side: Goldman Sachs upgraded its rating from “neutral” to “buy” on October 19, with a target price of $106, believing CoreWeave is “high quality among new cloud companies” (CNBC); Piper Sandler maintained “overweight”, lowering its target price from $153 to $124 (Yahoo Finance, October 21); Oppenheimer maintained “outperform” and a target price of $150, arguing that the bond sell-off amplified the market's concerns about risks (Investing.com, October 27). Jefferies, JPMorgan, and Cantor Fitzgerald also expressed in mid-October that the sell-off was “excessive” (CNBC, October 16).
The cautious side: HSBC maintained "reduce" with a target price of $39, the lowest on Wall Street; Morgan Stanley maintained “neutral”, lowering its target price from $99 to $70 (October 23). D.A. Davidson analyst Gil Luria publicly stated that if the AI cycle stalls, CoreWeave might be the first company to suffer the impact (Stocktwits, October 15).
Overall, according to LSEG data, among 45 analysts covering CoreWeave, 31 have given “buy” or “strong buy” ratings (CNBC, October 19).
Next catalyst: The company will announce its Q3 2026 performance on November 10 (Eastern Time) (CoreWeave investor relations announcement, October 27).
Heat: CNBC market page indicates a 10-day average trading volume of about 86.07 million shares. Following Oracle’s investor day on October 28, AI cloud stocks like CoreWeave also rose (Reuters).
Moderna ($MRNA): impressive year-to-date increase, clinical data triggering significant volatility
Recent performance: closed at $214.17 on October 28, up 2.98% for the day; as of October 28, year-to-date return is about +626% (Yahoo Finance). On October 21, it reached a closing price of $245.81, and on October 22, it dropped about 17.6% in one day, stabilizing and rebounding in subsequent trading days (stockcharted.com daily data).
Core catalyst: On October 22, Phase III data for Moderna’s personalized cancer vaccine developed in collaboration with Merck was leaked early. The data showed that combined treatment reduced the risk of recurrence or death by 42% for specific melanoma patients compared to using Keytruda alone. The results were generally regarded as positive, but market expectations were too high, causing the stock price to drop nearly 25% intraday (CNBC, October 22). The data was subsequently officially released at the ESMO 2026 conference and published in the New England Journal of Medicine, leading to a rebound in the stock price (Investing.com, October 28).
Analysts' views: William Blair downgraded its rating to "market perform," while Piper Sandler raised its target price (Investing.com, October 28).
Next catalyst: Q3 earnings are expected to be announced on November 6 (Investing.com, October 28).
Heat: On October 22, trading volume was approximately 49.95 million shares, 2–4 times that of the preceding trading days (stockcharted.com). Investing.com mentions that the implied volatility of options is at a high level.
Bloom Energy ($BE): correction after record earnings, then rebound
Recent performance: closed at $228.08 on October 28, up 4.38% for the day; as of October 28, year-to-date return is about +162.5% (Yahoo Finance). According to Motley Fool’s article from October 24, the stock price was over one-third below its historical peak at that time.
Core catalyst: On October 22, Q3 earnings report was released, recording revenue of $1.2358 billion, a 138.1% year-over-year increase; annual revenue guidance was raised to $4.4–4.6 billion (official press release from Bloom Energy). However, the free cash flow for the quarter was negative (about -$181 million), and the huge increase in contract assets became a focus of market discussion (Motley Fool). After the earnings report on October 23, the stock price dropped about 11.2% in one day, but rebounded for three consecutive trading days (stockcharted.com).
Analysts' views: Evercore ISI maintains an outperform rating (Investing.com, October 26).
Heat: On October 23, trading volume was about 36.02 million shares, 2–3 times that of earlier trading days (stockcharted.com).
Oracle ($ORCL): "presenting a financial plan" on investor day, with a significant one-day rise
Recent performance: closed at $144.54 on October 28, up 10.73% for the day (Yahoo Finance), with a trading volume of about 81.42 million shares, approximately three times that of most preceding trading days (Yahoo Finance historical data). Even so, it was still down about 25% for the year (Yahoo Finance, October 28).
Core catalyst: On October 28, during the investor day, Oracle set a target of over $225 billion in revenue for fiscal year 2030, expecting positive free cash flow in the second half of fiscal year 2028, with free cash flow exceeding $30 billion in fiscal year 2029. They also committed to a new financing limit of $20 billion for fiscal years 2027-2030, split equally between equity and debt (Oracle official press release; CNBC; Reuters).
Market background: Previously, the market mainly worried about Oracle’s high debt and dependence on a single client, OpenAI (Reuters). After the investor day, Oracle's stock price surged, and AI cloud stocks such as CoreWeave and Nebius also rose.
Regarding Google Trends search heat, X/Reddit discussion volume, and other social heat indicators: [to be supplemented] (No verifiable public data was obtained at the time of publication; it is recommended to add screenshots or data sources before release).
4. What highlights do these four contracts have?
CRWVUSDT: can be viewed as a "thermometer" for the financing environment of AI computing power. Changes in interest rates, credit spreads, and capital expenditures of large clients are often first reflected in its stock price. The earnings report on November 10 is the most closely watched event in the near term.
ORCLUSDT: a traditional software giant transitioning to AI cloud, the investor day provided a clearer financial roadmap. The subsequent progress of execution and whether the market accepts this plan remains to be seen.
BEUSDT: a representative stock for AI power demand, with key points on whether high growth can successfully translate into cash flow.
MRNAUSDT: a typical event-driven biotechnology stock, with clinical data, regulatory filings, and earnings reports potentially inducing significant volatility.
For users, this launch means being able to use stablecoins to track and trade in the same account the representative companies of the three popular themes of AI cloud, AI power, and biotechnology, without switching between different platforms. This is also BBX’s positioning: "One Account. Global Markets."
If you prefer to directly hold underlying stocks, the BBX stock sector also supports trading of over 6,000 U.S. and Hong Kong stocks using stablecoins.
About BBX
BBX is a multi-asset trading platform that accepts deposits in stablecoins, with a positioning of "One Account. Global Markets."
BBX uses stablecoins as a unified entry point for deposits, allowing users to access both traditional securities markets and on-chain multi-asset markets without repeatedly transferring funds between different platforms.
BBX Stock Account: Trading real U.S. and Hong Kong stocks, covering over 6,000 stocks. U.S. stock orders are executed by partnered broker-dealers registered with FINRA, and settlement and custody is provided by partnered clearing agencies; Hong Kong stock trading is executed by partnered securities companies holding licenses from the Hong Kong Securities and Futures Commission (SFC).
BBX Tokenized Stocks: On-chain trading of tokenized stocks on BBX DEX, available 24/7.
BBX Perpetual Contracts: Margined in USDT, covering stocks, ETFs, indices, commodities, and crypto assets, traded 24/7 on BBX DEX, with related settlements and independently verifiable trading records processed by on-chain infrastructure.
The leverage limit for BBX stock-related perpetual contracts varies by contract, with some contracts supporting up to 100x leverage.
Disclaimer
The content of this article is based on publicly available information and is for reference only; it does not constitute any investment advice, offer, or solicitation, nor does it constitute a recommendation or price prediction for any asset. The company data, stock performance, and analyst views in the article are sourced from public information and reflect the situation as of the publication date, which may change with market conditions. The specific rules and availability of the contracts are subject to BBX's official pages and announcements and are restricted by local laws and regulations.
Risk Warning
Perpetual contracts are leveraged derivatives, subject to significant price volatility, liquidity risks, and risk of forced liquidation; losses may exceed expectations. Stock perpetual contracts track the price of the underlying stocks; however, they do not represent holding stocks or enjoying shareholder rights, and the contract prices may deviate from the underlying stock prices. The underlying stocks in the U.S. markets may experience gaps during market closures, and events such as earnings reports and clinical data can also induce violent volatility. Please fully understand the product rules and trade cautiously according to your own risk tolerance.
Reference Sources
BBX Announcement: BBX Has Listed $CRWV Stock Perpetuals (2026-10-29) https://bbx.com/announcements/listings/5762962486814
BBX Announcement: BBX Has Listed 8 Perpetual Markets, Including $MRNA, $BE and $ORCL (2026-10-29) https://bbx.com/announcements/listings/5763268328222
BBX Official X: https://x.com/bbx_official/status/2115651588832543100; https://x.com/bbx_official/status/2115682542624116754
Yahoo Finance Market Pages $CRWV / $MRNA / $BE / $ORCL (Data as of October 28, 2026 market close)
Yahoo Finance: $ORCL Historical Prices https://finance.yahoo.com/quote/ORCL/history/
CNBC: $CRWV Market Page https://www.cnbc.com/quotes/CRWV
CNBC (2026-10-21): CoreWeave's market confidence erodes as bond yields spike
CNBC (2026-10-16): The drumbeat to buy battered shares of CoreWeave grows louder
Investing.com (2026-10-27): Oppenheimer holds $150 CoreWeave target
CoreWeave IR (2026-10-27): Q3 2026 Performance Release Announcement
CNBC (2026-10-22): Moderna shares plunge after cancer vaccine data leaks
Investing.com (2026-10-28): Why is Moderna stock rebounding today?
stockcharted.com: $MRNA, $BE Three-Month Daily Data (as of October 28, 2026)
Bloom Energy IR (2026-10-22): Q3 2026 Performance Press Release
Motley Fool (2026-10-24): Bloom Energy Raised Its 2026 Forecast for the Third Time
Investing.com (2026-10-26): Evercore ISI reiterates Bloom Energy stock rating
Oracle IR (2026-10-28): Oracle Investor Day 2026: Accelerating Value Creation
CNBC (2026-10-28): Oracle stock pops on forecast for 35% average growth through 2030
Reuters / Investing.com (2026-10-28): Oracle eases AI spending worries with plan to turn cash flow positive
Yahoo Finance (2026-10-28): Oracle stock soars as it promises the AI spending will start paying for itself
NVIDIA Form 13F (2026Q2, submitted on 2026-08-14): CoreWeave Holding https://www.filingexplorer.com/form13f-holding/21873S108/0001045810
NVIDIA Schedule 13G/A: CoreWeave Class A Shares hold of 11.5% https://www.stocktitan.net/sec-filings/CRWV/schedule-13g-a-core-weave-inc-amended-passive-investment-disclosure-6a00724c61b4.html
CNBC (2026-10-19): Buy neocloud stock CoreWeave, Goldman Sachs says https://www.cnbc.com/2026/10/19/buy-neocloud-stock-coreweave-goldman-sachs-says.html
Yahoo Finance (2026-10-21): CoreWeave Has Lost 51% in a Year: Piper Sandler Sees 100% Upside https://finance.yahoo.com/markets/stocks/articles/coreweave-lost-51-piper-sandler-195106311.html
Aries: $CRWV Analyst Ratings and Target Price Summary https://www.aries.com/us/en/stocks/CRWV/analysts
Sherwood News: CoreWeave’s rout spurs record retail buying https://sherwood.news/markets/coreweaves-rout-spurs-record-retail-buying/
Stocktwits (2026-10-15): CRWV Stock Flashes Red Again https://stocktwits.com/news-articles/markets/equity/crwv-stock-flashes-red-again-analyst-says-it-could-be-first-casualty-in-ai-downturn-retail-sniffs-opportunity/cZxWoVYRBA0
WallStreetNumbers: $CRWV Historical Volatility (as of 2026-10-27) https://wallstreetnumbers.com/stocks/crwv/volatility
Finviz: $CRWV Market and Volatility Data (as of 2026-10-28) https://finviz.com/stock?t=CRWV&ty=ocv
CNBC (2026-04-29): Bloom Energy shares rocket higher by 20%. It may be the new meme stock https://www.cnbc.com/2026/04/29/bloom-energy-shares-rocket-higher-by-20percent-it-may-be-the-new-meme-stock.html
CNBC (2026-04-14): Oracle jumps, Bloom Energy soars 20% on AI datacenter power deal https://www.cnbc.com/2026/04/14/oracle-orcl-bloom-energy-be-stock-data-center-ai-power.html
Motley Fool (2026-09-08): Bloom Energy Is Joining the S&P 500 https://www.fool.com/investing/2026/09/08/bloom-energy-is-joining-the-sp-500-is-the-stock-st/
TradingKey (2026-10-03): Bloom Energy Stock Price Forecast https://www.tradingkey.com/analysis/stocks/us-stocks/262198610-bloom-energy-stock-price-prediction-surge-86-ai-data-center-power-tradingkey
Motley Fool (2026-10-24): Bloom Energy Will Be the Biggest Winner of the AI Power Crunch https://www.fool.com/investing/2026/10/24/im-calling-it-bloom-energy-will-be-the-biggest-win/
Bloom Energy (2026): 2026 Power Report https://investor.bloomenergy.com/press-releases/press-release-details/2026/Data-Centers-Plan-to-Reduce-Reliance-on-Grid-Finds-Bloom-Energys-2026-Power-Report/default.aspx
Stocktwits (2026-10-22): BE Stock Extends Dip Overnight: Retail Bulls Hold Firm https://stocktwits.com/news-articles/markets/equity/be-stock-extends-dip-overnight-retail-bulls-hold-firm-as-ceo-says-power-demand-will-skyrocket-beyond-ai/cZxUz3tRBDN
BBX Official Website About Page https://bbx.com/about
免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到[email protected]，本平台相关工作人员将会进行核查。
